Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Xeris Pharmaceuticals
Xeris Pharmaceuticals
(XERS)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Keveyis
Dichlorphenamide
1982-01-01
Glaucoma
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Glucagon
hypoglycemia
,
type 1 diabetes mellitus
,
overweight
,
hyperglycemia
,
glucose metabolism disorders
,
metabolic diseases
,
metabolic syndrome
,
endocrine system diseases
,
weight loss
,
chronic renal insufficiency
,
kidney diseases
,
cardiovascular diseases
,
left ventricular dysfunction
,
coronary artery disease
,
type 2 diabetes mellitus
,
diabetes mellitus
,
obesity
,
fatty liver
,
body weight
,
weight gain
,
glucose intolerance
,
non-alcoholic fatty liver disease
,
knee osteoarthritis
,
osteoarthritis
Insulin
multiple myeloma
,
plasma cell neoplasms
,
carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
,
breast neoplasms
,
gestational diabetes
,
pregnancy in diabetics
,
leukemia
,
myocardial infarction
,
st elevation myocardial infarction
,
infarction
,
cystic fibrosis
,
hypercholesterolemia
,
obesity
,
overweight
,
weight loss
,
myocardial ischemia
,
diabetes mellitus
,
type 2 diabetes mellitus
,
type 1 diabetes mellitus
,
hyperglycemia
,
hypoglycemia
,
renal insufficiency
,
fibrosis
,
lipodystrophy
,
liver cirrhosis
,
ketosis
,
acidosis
,
diabetic ketoacidosis
,
retinal diseases
,
diabetic retinopathy
,
dyslipidemias
,
chronic obstructive pulmonary disease
,
lung diseases
,
obstructive lung diseases
,
emergencies
,
medication adherence
,
coronary artery disease
,
cardiovascular diseases
,
patient participation
,
insulin resistance
,
schizophrenia
Viaject
multiple myeloma
,
plasma cell neoplasms
,
carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
,
breast neoplasms
,
gestational diabetes
,
pregnancy in diabetics
,
leukemia
,
myocardial infarction
,
st elevation myocardial infarction
,
infarction
,
cystic fibrosis
,
hypercholesterolemia
,
obesity
,
overweight
,
weight loss
,
myocardial ischemia
,
diabetes mellitus
,
type 2 diabetes mellitus
,
type 1 diabetes mellitus
,
hyperglycemia
,
hypoglycemia
,
renal insufficiency
,
fibrosis
,
lipodystrophy
,
liver cirrhosis
,
ketosis
,
acidosis
,
diabetic ketoacidosis
,
retinal diseases
,
diabetic retinopathy
,
dyslipidemias
,
chronic obstructive pulmonary disease
,
lung diseases
,
obstructive lung diseases
,
emergencies
,
medication adherence
,
coronary artery disease
,
cardiovascular diseases
,
patient participation
,
insulin resistance
,
schizophrenia
Pram9
diabetes mellitus
,
type 1 diabetes mellitus
Pancreatin
exocrine pancreatic insufficiency
,
cystic fibrosis
,
pancreatitis
,
fibrosis
,
chronic pancreatitis
,
pancreatic neoplasms
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use